Advertisement
Journal of Oncology Practice  
Search for:
Limit by:
  Browse by Topic or Issue
Home Search or Browse JOP Subscriptions PDA Services E-mail Alerts Customer Service

Right arrow Help viewing high resolution images
Right arrow Return to article
ASCO permits users, at no charge, to download and make presentation slides of this material for personal and educational use, including noncommercial instruction and presentation at noncommercial conferences. Appropriate attribution to JOP is required. All other uses, including print distribution, require prior permission from ASCO.
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 1


Figure 1. Metabolic pathways of tamoxifen. The size of the arrow indicates the magnitude of the reaction. The most utilized pathway involves conversion of tamoxifen to N-desmethyltamoxifen by CYP3A. N-desmethylTAM is then converted to the most active antiestrogenic molecule, endoxifen, by CYP2D6. Adapted from Jin et al.3





Right arrow Return to article

About
JOP
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2010 by the American Society of Clinical Oncology, Online ISSN: 1935-469X. Print ISSN: 1554-7477
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JOP Online